Previous close | 129.72 |
Open | 129.60 |
Bid | 129.00 x 1300 |
Ask | 129.40 x 1100 |
Day's range | 126.61 - 133.29 |
52-week range | 17.91 - 178.50 |
Volume | 15,769,535 |
Avg. volume | 22,561,836 |
Market cap | 51.304B |
Beta (5Y monthly) | 1.72 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.63 |
Earnings date | 24 Feb 2021 - 01 Mar 2021 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 141.93 |
The US pharmaceutical giant, which has partnered with Germany’s BioNTech, has slowed shipments and distribution proceeds unevenly among states in the European Union.
President-elect Joe Biden released a $1.9 trillion COVID-19 response plan on Thursday evening, setting goals for his first 100 days in office, including a call for 100 million vaccinations by then.
Moderna (MRNA) closed at $124.06 in the latest trading session, marking a -0.39% move from the prior day.